Nuvo Research Provides Pennsaid® Update
MISSISSAUGA, ON, April 12, 2012 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a
specialty pharmaceutical company dedicated to building a portfolio of
products for the topical treatment of pain and the development of its
immune modulating drug candidate WF10, today provided an update on U.S.
developments relating to Pennsaid, its topical non-steroidal
anti-inflammatory drug (NSAID) used to treat the signs and symptoms of
osteoarthritis (OA) of the knee.
Pennsaid U.S.
Pennsaid is sold in the U.S.
Swank Capital and Cushing® MLP Asset Management Announce Rebalancing of the Cushing® MLP High Income Index
DALLAS, April 5, 2012 /PRNewswire/ -- Swank Capital, LLC and Cushing® MLP Asset Management, LP announced today that the 30 members of the Cushing® MLP High Income Index will be rebalanced after the market close on April 13, 2012 as part of normal index operations.
D3 Brings LED Display Technology to Landmark New York City Theatre Venues; Introduces First LED Marquee Display in Broadway Theatre History at Disney'
NEW YORK, March 26, 2012 /PRNewswire/ -- D3 LED, LLC (D3), the global leader in design, engineering and technology for the LED (light emitting diode) display market, today announced its completion of the first state-of-the-art LED display marquee and digital media system in Broadway theatre history for New Amsterdam Theatre at 214 West 42nd Street in New York City.
(Photo: )
Completed in 1903, the landmark New Amsterdam Theater is currently leased by The Walt Disney Corporation and is one of the oldest surviving Broadway theatres.
diaDexus, Inc. Highlights Findings from Two Outcomes Studies for its PLAC Lp-PLA(2) Activity Assay
SOUTH SAN FRANCISCO, Calif., March 19, 2012 /PRNewswire/ -- diaDexus, Inc. (OTC Bulletin Board: DDXS), a company focused on proprietary cardiovascular diagnostic products, today highlighted data from two recent studies evaluating the clinical utility of its PLAC® Test for Lp-PLA(2) Activity.
